Anne Assmus, PhD

Head of Global Business Development, Oncology & Immuno-Oncology

image

Novateur Advisor Since

2018

Field

Business Development

Specialties

Oncology Licensing

“We integrate a variety of disciplines that require an analytical, detail-oriented mind but also the big picture perspective and a feel for people."

Anne Assmus, PhD
Head of Global Business Development, Oncology & Immuno-Oncology

Dr. Anne Assmus has over 10 years of international experience in biotech business development and strategic consulting. Prior to joining Affimed, Dr. Assmus worked as Senior Consultant at a Boston-based boutique consultancy and was Senior Manager of Business Development at Immatics Biotechnologies GmbH in Tuebingen, Germany, a peptide-MHC identification, vaccines, and T-cell therapy company. Before Immatics, Dr. Assmuss was Manager of Business Development at MorphoSys AG in Munich, Germany, one of the world’s leading antibody technology companies, and Marketing Analyst at Novozymes A/S in Bagsvaerd, Denmark.

Dr. Assmus holds a PhD in Economics Industry from the University of Passau, a Master’s degree in Biology from Heidelberg University, and a Bachelor of Science degree in International Business from Copenhagen Business School.

Novateur
Newsletter

Subscribe to our newsletter for access to latest updates.

Resource
Databases

Access Novateur news as well as FDA and Expert Databases.

Relevant
Events

Check out conferences and events we are attending!

Article
Features

Read articles by our team! Featured in BioteCanada Insights and Nature among others.